Source:http://linkedlifedata.com/resource/pubmed/id/16931830
Switch to
Predicate | Object |
---|---|
rdf:type | |
lifeskim:mentions | |
pubmed:issue |
7565
|
pubmed:dateCreated |
2006-8-25
|
pubmed:commentsCorrections | |
pubmed:language |
eng
|
pubmed:journal | |
pubmed:citationSubset |
AIM
|
pubmed:chemical | |
pubmed:status |
MEDLINE
|
pubmed:month |
Aug
|
pubmed:issn |
1468-5833
|
pubmed:author | |
pubmed:issnType |
Electronic
|
pubmed:day |
26
|
pubmed:volume |
333
|
pubmed:owner |
NLM
|
pubmed:authorsComplete |
Y
|
pubmed:pagination |
409
|
pubmed:dateRevised |
2011-11-17
|
pubmed:meshHeading |
pubmed-meshheading:16931830-Antibodies, Monoclonal,
pubmed-meshheading:16931830-Antibodies, Monoclonal, Humanized,
pubmed-meshheading:16931830-Antineoplastic Agents,
pubmed-meshheading:16931830-Breast Neoplasms,
pubmed-meshheading:16931830-Female,
pubmed-meshheading:16931830-Humans,
pubmed-meshheading:16931830-Practice Guidelines as Topic
|
pubmed:year |
2006
|
pubmed:articleTitle |
Final guidance issued on Herceptin after appeal rejected.
|
pubmed:publicationType |
News
|